Peptides and prehistoric survival: fact-checking the evolutionary angle

What's this video probably claiming?

Based on the caption referencing "the only humans that are still standing" alongside hashtags about Homo sapiens, early humans, and prehistoric life, this creator is almost certainly leaning on evolutionary biology to make a case for peptide therapy. The framing tends to go something like this: our ancestors survived brutal conditions, their bodies produced certain peptides in abundance, and modern humans are now deficient because we live soft, sedentary lives. Therefore, supplementing with exogenous peptides like BPC-157, TB-500, or GHK-Cu is just "restoring" what evolution gave us. It's a compelling narrative. It's also doing a lot of heavy lifting with very thin scientific thread connecting the evolutionary premise to the clinical intervention being sold. Creators in this space routinely conflate anthropological resilience with biochemical supplementation need, which are genuinely different arguments.

What does the science actually show?

Peptides like BPC-157 (Body Protection Compound) are real, and some early research is legitimately interesting. Sikiric et al. (2018, Current Pharmaceutical Design) documented significant wound-healing and gastroprotective effects in rodent models. GHK-Cu has shown collagen synthesis stimulation and wound repair activity in vitro, with Pickart and Margolina (2018, Biomolecules) reviewing decades of copper peptide research. TB-500, a synthetic fragment of Thymosin Beta-4, showed cardiac repair potential in animal models (Bock-Marquette et al., 2004, Nature). Here's the problem: essentially all of this is preclinical. Rodent models do not translate cleanly to human physiology, and none of these compounds have completed Phase III randomized controlled trials in humans for the recovery or anti-aging indications being promoted on social media. The evolutionary argument adds zero clinical weight to this data gap.

Where does the social media noise diverge from clinical reality?

The "ancestral survival" framing is rhetorically smart but scientifically irrelevant to whether injecting a synthetic peptide at a specific dose produces a specific human health outcome. Our Paleolithic ancestors were not surviving because of exogenous BPC-157 administration. They were surviving despite extraordinarily high mortality rates, not because of some peptide-rich biological superstate we've lost. Life expectancy estimates for prehistoric humans range from 25 to 37 years at birth (Gurven and Kaplan, 2007, Population and Development Review), which rather undercuts the "they were doing something right" narrative. Social media peptide content also routinely skips past the regulatory reality: most of these compounds are not FDA-approved for human use outside of narrow research contexts, and compounded versions vary significantly in purity, potency, and sterility.

What should you actually know?

If you're interested in peptide therapy because you saw a TikTok about prehistoric human resilience, that's a perfectly reasonable starting point for curiosity, but a poor basis for a clinical decision. Here's what the evidence actually supports: BPC-157 has shown anti-inflammatory and mucosal-healing effects in animal studies consistently enough that researchers consider it worth further human investigation. GHK-Cu has legitimate topical skincare data behind it. Ipamorelin and CJC-1295 are growth hormone secretagogues with some human pharmacokinetic data (Walker, 2006, Growth Hormone and IGF Research). None of these carry the disease-treatment claims that float around social media. A regulated telehealth provider will evaluate your individual labs, history, and goals, not your enthusiasm for a prehistoric survival metaphor. The evolutionary framing is a marketing device, not a mechanism of action.